Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 242,249 | 168,130 | 160,215 | 179,338 | 172,561 |
| Receivables | 52,373 | 94,944 | 80,738 | 66,238 | 30,681 |
| Inventories | 62,533 | 66,030 | 71,268 | 14,643 | 16,325 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,264 |
| TOTAL | $383,632 | $345,449 | $327,203 | $273,115 | $234,015 |
| Non-Current Assets | |||||
| PPE Net | 304,211 | 302,455 | 303,468 | 264,240 | 263,056 |
| Intangibles | 105,765 | 113,866 | 116,116 | 44,102 | 45,065 |
| Other Non-Current Assets | 75,683 | 75,479 | 76,464 | 45,173 | 53,328 |
| TOTAL | $485,659 | $491,800 | $496,048 | $353,515 | $361,449 |
| Total Assets | $869,291 | $837,249 | $823,251 | $626,630 | $595,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,488 | N/A | N/A | N/A | 4,470 |
| Accounts payable and accrued liabilities | 39,351 | 36,968 | 36,643 | 27,521 | 29,018 |
| Accrued Expenses | 31,538 | 26,001 | 23,121 | 25,867 | 19,780 |
| Other current liabilities | 2,139 | 8,037 | 7,292 | 1,341 | 1,326 |
| TOTAL | $81,417 | $76,427 | $72,324 | $56,651 | $56,632 |
| Non-Current Liabilities | |||||
| Long Term Debt | 251,000 | 251,000 | 251,000 | 62,000 | 54,952 |
| Deferred Revenues | 5,813 | 5,333 | 5,180 | 1,834 | 2,038 |
| Other Non-Current Liabilities | 17,921 | 20,423 | 20,627 | 17,400 | 17,023 |
| TOTAL | $274,736 | $273,055 | $273,432 | $80,814 | $71,975 |
| Total Liabilities | $356,153 | $349,482 | $345,756 | $137,465 | $128,607 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,552 | 37,477 | 37,411 | 36,772 | 36,367 |
| Common Shares | 38 | 38 | 38 | 37 | 37 |
| Retained earnings | 258,152 | 236,321 | 231,292 | 251,528 | 236,305 |
| Other shareholders' equity | -3,929 | -3,370 | -3,510 | -4,037 | -3,857 |
| TOTAL | $513,138 | $487,767 | $477,495 | $489,165 | $466,857 |
| Total Liabilities And Equity | $869,291 | $837,249 | $823,251 | $626,630 | $595,464 |